Unparalleled precision of SPEAR UltraDetect immunoassays with homogeneous format: GFAP and NfL

15 Jan 2026

This application note showcases the exceptional analytical performance of SPEAR UltraDetect homogeneous immunoassays for the quantification of the neurological biomarkers GFAP and NfL. Designed to overcome the limitations of conventional ultra-sensitive platforms, SPEAR UltraDetect delivers an unprecedented combination of ultra-high sensitivity, superior precision, and robust reproducibility, even at the lowest biomarker concentrations found in blood.

Links

Tags